The role of mast cells in the development of 2, 4, 6-trinitrobenzene sulfonic acid-induced colitis in rats

Scandinavian Journal of Gastroenterology

Volumn 37, Issue 5, 2002, Pages 555-560

  Fukumoto, Y ^a   Kasai, H ^a   Takahashi, H ^a   Sugiyama, H ^a   Hase, N ^a   Kaneko, H ^a   Hamamura, I ^a   Aoki, Y ^a   Ota, M ^a   Kobayashi, T ^a   Katsuura, Y ^a   Kamimura, T ^a   Komoriya, K ^a  

^a TEIJIN LTD   (Japan)

Author keywords

2,4,6 trinitrobenzene sulfonic acid (TNBS); Crohn disease; Inflammatory bowel disease; Mast cell; Rat mast cell protease (RMCP); Ws Ws rats

Indexed keywords

ALCOHOL; PROTEINASE; TRINITROBENZENESULFONIC ACID; CHYMASE; CHYMASE 2; SERINE PROTEINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL FUNCTION; COLON; COLON INJURY; CONTROLLED STUDY; CROHN DISEASE; MALE; MAST CELL; NONHUMAN; ORGAN WEIGHT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; ANIMAL; ANIMAL MODEL; CHEMICALLY INDUCED DISORDER; COLITIS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

ANIMAL; COLITIS; COLON; CROHN DISEASE; MALE; MAST CELLS; MODELS, ANIMAL; RATS; SERINE ENDOPEPTIDASES; TRINITROBENZENESULFONIC ACID; ANIMALS; CHYMASES;

EID: 0036000210     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365520252903107     Document Type: Article

References (40)

1. The role of mast cells and basophils in inflammation
2. Release of mast cell tryptase from human colorectal mucosa in inflammatory bowel disease
3. Strictures in Crohn's disease are characterised by an accumulation of mast cells colocalised with laminin but not with fibronectin or vitronectin
4. A quantitative immunohistological evaluation of inflammatory cells at the affected and unaffected sites of inflammatory bowel disease
5. Colonic mucosal mast cell distribution at line of demarcation of active ulcerative colitis
6. Enhancement of human intestinal mast cell mediator release in active ulcerative colitis
7. Histamine release from gut mast cells from patients with inflammatory bowel diseases
8. Increased colonic mucosal mast cells associated with severe watery diarrhea and microscopic colitis
9. Mast cells and paneth cells in ulcerative colitis
10. Mast cells in inflammatory conditions of the gastrointestinal tract
11. Corticosteroid treatment reduces mast cell numbers in inflammatory bowel disease
12. Crohn's disease: Transmission electron microscopic studies. II. Immunologic inflammatory response. Alterations of mast cells, basophils, eosinophils, and the microvasculature
13. Mast-cell degranulation in Crohn's disease
14. Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation
15. Anemia and mast cell depletion in mutant rats that are homozygous at 'white spotting (Ws)' locus
16. Therapy of inflammatory bowel disease
17. A novel method in the induction of reliable experimental acute and chronic colitis in mice
18. Effects of dextran sulphate sodium on intestinal epithelial cells and intestinal lymphocytes
19. An orally administered growth factor extract derived from bovine whey suppresses breath ethane in colitic rats
20. Hapten-induced model of chronic inflammation and ulceration in the rat colon
21. Experimental colitis in animal models [Review]
22. Experimental colitis induced by trinitrobenzenesulfonic acid: An ultrastructural and histochemical study
23. Lack of crucial role of mast cells in pathogenesis of experimental colitis in mice
24. Development of dextran sulphate sodium-induced experimental colitis is suppressed in genetically mast cell-deficient Ws/Ws rats
25. Mast cells are not essential to inflammation in murine model of colitis
26. Expression of the mast cell growth factor interleukin-3 in melanocytic lesions correlates with an increased number of mast cells in the perilesional stroma: Implications for melanoma progression
27. Role of histamine in a rat model of colitis
28. Platelet-activating factor mediates trinitrobenzene induced colitis
29. Effect of leukotriene C4D4 antagonist on colonic damage induced by intracolonic administration of trinitrobenzene sulfonic acid in rats
30. Response to heparin in patients with ulcerative colitis
31. The effect of heparin on trinitrobenzene sulphonic acid-induced colitis in the rat
32. Heparin in inflammation: Potential therapeutic applications beyond anticoagulation
33. Rapid intestinal ischaemia-reperfusion injury is suppressed in genetically mast cell-deficient Ws/Ws rats
34. Infection of Nippostrongylus brasiliensis induces development of mucosal-type but not connective tissue-type mast cells in genetically mast cell-deficient Ws/Ws rats
35. Lack of active lung anaphylaxis in congenitally mast cell-deficient Ws/Ws rats sensitized with the nematode Nippostrongylus brasiliensis
36. Evaluation of role of mast cells in the development of liver fibrosis using mast cell-deficient rats and mice
37. The possible role of LTC4 in the pathogenesis of ethanol-induced gastric lesions in mice and their prevention by 5-lipoxygenase inhibitor AA-861, and leukotriene receptor antagonist FPL-55712
38. Evaluation of the role of mast cells in the progression of acetic acid-induced colitis in mice
39. Reactivation of hapten-induced colitis and its prevention by anti-inflammatory drugs
40. The role of CD4+ lymphocytes in the susceptibility of mice to stress-induced reactivation of experimental colitis